Coloplast is trading at 8.45 as of the 5th of February 2026; that is 3.17% up since the beginning of the trading day. The stock's open price was 8.19. Coloplast has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 7th of November 2025 and ending today, the 5th of February 2026. Click here to learn more.
Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.. The company has 2.12 B outstanding shares. More on Coloplast A
Coloplast A [CLPBY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast A classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 2.12 B outstanding shares.
Coloplast A has accumulated about 854 M in cash with 5.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Check Coloplast Probability Of BankruptcyOwnership AllocationColoplast holds a total of 2.12 Billion outstanding shares. Almost 99.99 percent of Coloplast outstanding shares are held by general public with 0.01 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Coloplast Ownership Details
The company last dividend was issued on the 2nd of December 2022. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.The quote for Coloplast A is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Coloplast A please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.
Coloplast A Investment Alerts
Coloplast A generated a negative expected return over the last 90 days
Coloplast Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 24.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Coloplast Profitablity
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.3 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.3.
Technical Drivers
As of the 5th of February, Coloplast shows the Mean Deviation of 1.07, standard deviation of 1.51, and Risk Adjusted Performance of (0.02). Coloplast A technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
The output start index for this execution was zero with a total number of output elements of sixty-one. Coloplast A Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Coloplast price patterns.
Coloplast Outstanding Bonds
Coloplast issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Coloplast A uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Coloplast bonds can be classified according to their maturity, which is the date when Coloplast A has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Coloplast intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Coloplast pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Coloplast's time-series forecasting models are one of many Coloplast's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coloplast's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Coloplast without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Share Portfolio Now
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.